Lucid Diagnostics (LUCD) Net Margin (2021 - 2026)

Lucid Diagnostics has reported Net Margin for 6 years, with the latest figure at 1817.54% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin rose 253246.0% year-over-year to 1817.54%; the trailing twelve-month figure through Mar 2026 stood at 1117.97% (up 58189.0% YoY), and the FY2025 full-year result was 1499.55%, down 27947.0% from the prior year.
• Net Margin for Q1 2026 stood at 1817.54%, down from 1081.52% in the prior quarter.
• The five-year high for Net Margin was 657.33% in Q2 2025, with the low at 18880.26% in Q3 2022.
• Historically, Net Margin has averaged 4130.41% across 5 years, with a median of 1811.78% in 2023.
• Annual changes were most pronounced in 2022 — Net Margin sank 1540176 bps — and 2023, when it soared 1706570 bps.
• Lucid Diagnostics' Net Margin stood at 13328.57% in 2022, then soared by 92 bps to 1041.35% in 2023, then gained by 7 bps to 964.16% in 2024, then dropped by 12 bps to 1081.52% in 2025, then sank by 68 bps to 1817.54% in 2026.
• The last three Net Margin figures came in at 1817.54% (Q1 2026), 1081.52% (Q4 2025), and 866.42% (Q3 2025), per Business Quant data.